High potency API
PrEP (pre-exposure prophylaxis) medications are crucial in the fight against HIV because they can prevent people from getting HIV in the first place. PrEP is a daily pill or injection that can reduce the risk of getting HIV from sex Continue reading Generic PrEP medications
Recent Developments in licensing In July 2022, ViiV Healthcare, the manufacturer of cabotegravir, signed a voluntary licensing agreement with the Medicines Patent Pool (MPP). This agreement allows generic manufacturers to produce and supply cabotegravir in 90 low- and middle-income countries. Continue reading How licensing agreements can save lives in low- and middle income countries
Cabotegravir is a long-acting HIV integrase inhibitor that is injected every two months for the treatment or prevention of HIV. It is a highly effective medication, and its long-acting formulation makes it a convenient option for many people living with Continue reading Cabotegravir
Biologicals, also known as biopharmaceuticals or biologic drugs, are a diverse group of medications derived from living organisms or their components. Unlike traditional drugs, which are typically small molecules synthesized chemically, biologicals are large, complex molecules produced through biological processes. Continue reading Biologicals
Collagenase: A Versatile Enzyme with Diverse Applications Collagenase is an enzyme that breaks down collagen, a type of protein that is found in connective tissues throughout the body. Collagenase is produced by a variety of bacteria, including Clostridium histolyticum. Collagenase Continue reading Collagenase
Oligonucleotide drugs, also known as antisense drugs, are a type of medication designed to target specific genes in order to treat or prevent diseases. They work by binding to messenger RNA (mRNA) molecules and blocking their ability to produce certain Continue reading More Oligonucleotide Drugs Approved
Nusinersen is an oligonucleotide drug approved by the FDA in 2016 for the treatment of spinal muscular atrophy (SMA). SMA is a rare genetic disease that affects the muscles used for movement, breathing, and swallowing. Nusinersen is the first and Continue reading Nusinersen API